Pozniak A - Search Results

1

Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase.

Winston A, Pozniak A, Mandalia S, Gazzard B, Pillay D, Nelson M. Winston A, et al. Among authors: pozniak a. AIDS. 2004 Apr 9;18(6):949-51. doi: 10.1097/00002030-200404090-00014. AIDS. 2004. PMID: 15060444 No abstract available.

2

Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy.

Mihailidis C, Dunn D, Pillay D, Pozniak A. Mihailidis C, et al. Among authors: pozniak a. AIDS. 2008 Jan 30;22(3):427-30. doi: 10.1097/QAD.0b013e3282f3744f. AIDS. 2008. PMID: 18195570

3

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients.

Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. Winston A, et al. Among authors: pozniak a. AIDS. 2002 Oct 18;16(15):2087-9. doi: 10.1097/00002030-200210180-00018. AIDS. 2002. PMID: 12370512

4

Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?

Winston A, Pozniak A, Smith N, Fletcher C, Mandalia S, Parmar D, Gibbons S, Back D, Gazzard B, Nelson M. Winston A, et al. Among authors: pozniak a. AIDS. 2004 Feb 20;18(3):572-4. doi: 10.1097/00002030-200402200-00029. AIDS. 2004. PMID: 15090815 Clinical Trial.

5

Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.

Boffito M, Winston A, Jackson A, Fletcher C, Pozniak A, Nelson M, Moyle G, Tolowinska I, Hoetelmans R, Miralles D, Gazzard B. Boffito M, et al. Among authors: pozniak a. AIDS. 2007 Jul 11;21(11):1449-55. doi: 10.1097/QAD.0b013e3282170ab1. AIDS. 2007. PMID: 17589191

6

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.

Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A; NEAT001/ANRS143 Study Group. Raffi F, et al. Among authors: pozniak a. Lancet. 2014 Nov 29;384(9958):1942-51. doi: 10.1016/S0140-6736(14)61170-3. Epub 2014 Aug 4. Lancet. 2014. PMID: 25103176 Clinical Trial.

7

A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).

Stebbing J, Nelson M, Orkin C, Mandalia S, Bower M, Pozniak A, Gazzard B. Stebbing J, et al. Among authors: pozniak a. J Antimicrob Chemother. 2004 Mar;53(3):501-5. doi: 10.1093/jac/dkh116. Epub 2004 Feb 4. J Antimicrob Chemother. 2004. PMID: 14762056 Clinical Trial.

8

Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects.

Boffito M, Back D, Stainsby-Tron M, Hill A, Di Perri G, Moyle G, Nelson M, Tomkins J, Gazzard B, Pozniak A. Boffito M, et al. Among authors: pozniak a. Br J Clin Pharmacol. 2005 Jan;59(1):38-42. doi: 10.1111/j.1365-2125.2004.02240.x. Br J Clin Pharmacol. 2005. PMID: 15606438 Free PMC article.

9

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

Phillips AN, Dunn D, Sabin C, Pozniak A, Matthias R, Geretti AM, Clarke J, Churchill D, Williams I, Hill T, Green H, Porter K, Scullard G, Johnson M, Easterbrook P, Gilson R, Fisher M, Loveday C, Gazzard B, Pillay D; UK Collaborative Group on HIV Drug Resistance; UK CHIC Study Group. Phillips AN, et al. Among authors: pozniak a. AIDS. 2005 Mar 25;19(5):487-94. doi: 10.1097/01.aids.0000162337.58557.3d. AIDS. 2005. PMID: 15764854

10

Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.

Waters LJ, Moyle G, Bonora S, D'Avolio A, Else L, Mandalia S, Pozniak A, Nelson M, Gazzard B, Back D, Boffito M. Waters LJ, et al. Among authors: pozniak a. Antivir Ther. 2007;12(5):825-30. Antivir Ther. 2007. PMID: 17713166 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page